Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy

被引：0
|
作者：
Benjamin J. Gigliotti
Sina Jasim
机构：
[1] University of Rochester School of Medicine & Dentistry,Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism
[2] Washington University in St. Louis,Department of Medicine, Division of Endocrinology, Metabolism and Lipid Research
来源：
Endocrine | 2024年 / 83卷
关键词：
Differentiated thyroid cancer; Thyroid hormone replacement; Levothyroxine; TSH suppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：7
相关论文
共 50 条
  • [1] Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy
    Gigliotti, Benjamin J.
    Jasim, Sina
    [J]. ENDOCRINE, 2024, 83 (02) : 251 - 258
  • [2] Use of Post-Operative External Beam Radiation Therapy in Patients with Differentiated Thyroid Cancer
    Brown, A.
    Kellogg, A.
    Mirza, Z.
    Sears, T.
    Krempl, G. A.
    Henson, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1197 - 1197
  • [3] Thyroid hormone therapy in differentiated thyroid cancer
    Giorgio Grani
    Valeria Ramundo
    Antonella Verrienti
    Marialuisa Sponziello
    Cosimo Durante
    [J]. Endocrine, 2019, 66 : 43 - 50
  • [4] Thyroid hormone therapy in differentiated thyroid cancer
    Grani, Giorgio
    Ramundo, Valeria
    Verrienti, Antonella
    Sponziello, Marialuisa
    Durante, Cosimo
    [J]. ENDOCRINE, 2019, 66 (01) : 43 - 50
  • [5] Post-operative complications after completion thyroidectomy for differentiated thyroid cancer
    Pezzullo, L
    Delrio, P
    Losito, NS
    Caraco, C
    Mozzillo, N
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (03): : 215 - 218
  • [6] Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer
    Alfredo Campennì
    Salvatore Antonio Pignata
    Sergio Baldari
    [J]. Clinical and Translational Imaging, 2018, 6 : 347 - 355
  • [7] Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low-intermediate risk differentiated thyroid cancer
    Campenni, Alfredo
    Pignata, Salvatore Antonio
    Baldari, Sergio
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (05) : 347 - 355
  • [8] Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer
    Schumm, Max A.
    Lechner, Melissa G.
    Shu, Michelle L.
    Ochoa, Joana E.
    Kim, Jiyoon
    Tseng, Chi-Hong
    Leung, Angela M.
    Yeh, Michael W.
    [J]. ENDOCRINE PRACTICE, 2021, 27 (07) : 691 - 697
  • [9] Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer
    Pujol, P
    Daures, JP
    Nsakala, N
    Baldet, L
    Bringer, J
    Jaffiol, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12): : 4318 - 4323
  • [10] Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer
    Zoltek, Maximilian
    Andersson, Therese M-L
    Axelsson, Erland
    Hedman, Christel
    Lundgren, Catharina Ihre
    [J]. CANCERS, 2022, 14 (10)
12345